Literature DB >> 26282467

Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.

G Kelly1, R Hughes1, T McGarry2,3, M van den Born1, K Adamzik4, R Fitzgerald5, C Lawlor6, A M Tobin5, C M Sweeney1, B Kirby4.   

Abstract

BACKGROUND: There is a dearth of information on the precise pathogenesis of hidradenitis suppurativa (HS), but immune dysregulation is implicated.
OBJECTIVES: To determine the nature of the immune response in HS.
METHODS: Skin biopsies - lesional, perilesional (2 cm away) and uninvolved (10 cm away) - were obtained from patients with HS and healthy controls. The expression of various cytokines was determined by enzyme-linked immunosorbent assay, flow cytometry and real-time polymerase chain reaction.
RESULTS: The expression of the inflammatory cytokines interleukin (IL)-17, IL-1β and tumour necrosis factor-α was enhanced in lesional skin of patients with HS. In addition, IL17A and IL1B mRNA were enhanced in clinically normal perilesional skin. CD4(+) T cells produced IL-17 in HS, while CD11c(+) CD1a(-) CD14(+) cells were sources of IL-1β. Activated caspase-1 was detected in HS skin and was associated with enhanced expression of NLRP3 and IL18. Inhibition of caspase-1 decreased IL-1β and IL-18 production, suggesting that the caspase-1 pathway participates in IL-1β and IL-18 expression in HS. Abnormal cytokine expression was detected in perilesional and uninvolved skin, which may suggest that subclinical inflammation is present in HS skin prior to the formation of an active lesion.
CONCLUSIONS: This study demonstrates that CD4(+) T cells produce IL-17 in HS and that the IL-17 pathway may be important in HS pathogenesis. CD11c(+) CD1a(-) CD14(+) cells are a source of IL-1β in HS, the production of which was shown to be mediated, in part, via a caspase-1-dependent pathway. These results suggest that IL-17 and the caspase-1-associated cytokines IL-1β and IL-18 may play a role in the pathogenesis of HS.
© 2015 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26282467     DOI: 10.1111/bjd.14075

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  62 in total

Review 1.  Hidradenitis Suppurativa: Causes, Features, and Current Treatments.

Authors:  Caroline Vinkel; Simon Francis Thomsen
Journal:  J Clin Aesthet Dermatol       Date:  2018-10-01

2.  Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.

Authors:  S Hessam; M Sand; M Skrygan; T Gambichler; F G Bechara
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

Review 3.  Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease.

Authors:  Holly Anderton; Ian P Wicks; John Silke
Journal:  Nat Rev Rheumatol       Date:  2020-07-08       Impact factor: 20.543

Review 4.  An Update on Medical Treatment Options for Hidradenitis Suppurativa.

Authors:  I E Deckers; E P Prens
Journal:  Drugs       Date:  2016-02       Impact factor: 9.546

Review 5.  [Acne inversa/hidradenitis suppurativa: An update].

Authors:  R Sabat; A Tsaousi; J Rossbacher; H Kurzen; T Fadai; U Schwichtenberg; S Schneider-Burrus; G Kokolakis; K Wolk
Journal:  Hautarzt       Date:  2017-12       Impact factor: 0.751

6.  Prevalence of positive QuantiFERON gold in-tube testing in hidradenitis suppurativa.

Authors:  Tina Boortalary; Kanchan Misra; Sean McNish; Derek Jones; Victoria K Shanmugam
Journal:  J Dermatolog Treat       Date:  2018-01-22       Impact factor: 3.359

7.  Prevalence of antinuclear antibodies in hidradenitis suppurativa.

Authors:  Shaunak Mulani; Sean McNish; Derek Jones; Victoria K Shanmugam
Journal:  Int J Rheum Dis       Date:  2018-05       Impact factor: 2.454

8.  Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease.

Authors:  Britta Siegmund; Roger M Feakins; Giorgos Barmias; Juliano Coelho Ludvig; Fabio Vieira Teixeira; Gerhard Rogler; Michael Scharl
Journal:  J Crohns Colitis       Date:  2015-12-17       Impact factor: 9.071

Review 9.  The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.

Authors:  Ahmed Shah; Raed Alhusayen; Saeid Amini-Nik
Journal:  Inflamm Res       Date:  2017-06-27       Impact factor: 4.575

10.  Pathogenetic Characteristics of Mesenchymal Stem Cells in Hidradenitis Suppurativa.

Authors:  Anna Campanati; Monia Orciani; Giulia Sorgentoni; Veronica Consales; Annamaria Offidani; Roberto Di Primio
Journal:  JAMA Dermatol       Date:  2018-10-01       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.